Loading market data...
Latest Top News
Show more
Abbott Healthcare Under Scrutiny in India Over Cough Syrup Abuse Investigation
Abbott Healthcare is facing regulatory scrutiny in India following an investigation into alleged cough syrup abuse, according to official documents. Authorities are examining the company’s practices and compliance standards amid concerns over misuse of pharmaceutical products. The probe highlights growing regulatory vigilance in India’s healthcare sector and its focus on patient safety.
Stay Ahead – Explore Now! Gold Hits Multi-Week High Amid Inflation Fears and Trump’s Tariff Hints






